Company profile for Lyvgen

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Lyvgen was founded in 2016 by Jieyi Wang, Ph.D, who serves as the Chairman and CEO. Previously, Dr. Wang worked at Abbott/AbbVie for 22 years in Oncology R&D with extensive experience in new drug discovery, cancer biology and immunotherapy. Lyvgen has completed its Series A funding through Morningside Venture. Recently Lyvgen closed a USD $30 million Series B funding round. 6 Dimensions Capital led this round of financing, wit...
Lyvgen was founded in 2016 by Jieyi Wang, Ph.D, who serves as the Chairman and CEO. Previously, Dr. Wang worked at Abbott/AbbVie for 22 years in Oncology R&D with extensive experience in new drug discovery, cancer biology and immunotherapy. Lyvgen has completed its Series A funding through Morningside Venture. Recently Lyvgen closed a USD $30 million Series B funding round. 6 Dimensions Capital led this round of financing, with participation from Winfair Global, Runling Capital and existing Series A investor Morningside Ventures.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Room 601B, Building 8, No. 1043 Harley Road
Telephone
Telephone
+1 (650) 453-8006
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

ICMD China

ICMD China

Not Confirmed

envelop Contact Supplier

ICMD China

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.clinicaltrialsarena.com/news/lyvgen-bms-cancer-antibody-trial/

CLINICALTRIALSARENA
28 Nov 2022

https://www.prnewswire.com/news-releases/lyvgen-announces-phase-2-clinical-collaboration-with-bristol-myers-squibb-to-evaluate-lvgn7409-in-combination-with-nivolumab-in-non-small-cell-lung-cancer-patients-301687459.html

PRNEWSWIRE
27 Nov 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty